International Journal of Angiology

, Volume 8, Issue 2, pp 98–101 | Cite as

Microshunt histology in telangiectasias

  • Imre Bihari
  • Éva Magyar
Original Articles

Abstract

Telangiectatic spiders occur in 10–14% of the population. Recently, the most widely accepted theory of their origin is perforator incompetence and venous hypertension. In spite of that, various authors have suggested that arteriovenous (AV) shunts may contribute their etiology. Based on this theory, continuous wave, Doppler-drived biopsies were taken for histological examination. A total of 132 telangiectatic subjects were examined and in 91 cases, pulsatile sound of a tiny artery was detected over the spider. In 18 of the positive cases, a 2.5×1.5 cm specimen was excised for histology. In 16 of them, AV microshunt could be proved. According to this result it may be that AV microshunts have a role in the etiology and complication of sclerotherapy of some telangiectatic spiders.

References

  1. 1.
    Guberan E, Widmer KL, Rougemont A (1974) Epidemiology of spider webs. VASA 3:391–395.Google Scholar
  2. 2.
    Willerhausen WE, Marschall M (1984) Prevalenz, Risikofaktoren und Komplikationen peripherer Venenerkrankungen in der Münchner Bevölkerung. Hautarzt 35:60–77.Google Scholar
  3. 3.
    Biegeleisen K (1987) Primary lower extremity teleangiectasias—relationship of size and color. Angiology 38:760–768.Google Scholar
  4. 4.
    Bihari I, Magyar É, Dér J (1987) Varicosités par fistule artérioveneuse aquise non traumatique. Phlébologie 40:117–121.Google Scholar
  5. 5.
    Bihari I, Magyar É, Dér J (1986) An aquired, nontraumatic arteriovenous shunt varicosity. In: Phlebology '85, Negus D, Jantet G (eds). John Libbey & Co: London, Paris, pp 776–779.Google Scholar
  6. 6.
    Brunner H (1982) Dolente Besenreiservarizen. VASA 11:235–236.Google Scholar
  7. 7.
    Goldman MP (1991) Sclerotherapy. Treatment of Varicose and Telangiectatic Leg Veins. Mosby Year Book: St. Louis, Baltimore, Boston, Chicago, London, Philadelphia, Sydney, Toronto, pp 26–106.Google Scholar
  8. 8.
    Green AR, Morgan BDG (1985) Sclerotherapy of venous flare. Br J Plast Surg 38:241–242.Google Scholar
  9. 9.
    Bergan JJ (1995) Sclerotherapy: Technique and application. In: Vascular Surgery, Rutherford RB (ed). Saunders: Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, pp 1828–1836.Google Scholar
  10. 10.
    Raymond-Martimbeau P, Dupuis JL (1995) Telangiectasias: Incidence, Classification, and Relationship with Superficial and Deep Venous Systems: a Double-Blind Study. In: Phlebology 95, Negus D et al. (eds). Phlebology Suppl, pp 1:169–71.Google Scholar
  11. 11.
    Somjen GM, Ziegenbien R, Johnston AH, Royle JP (1993) Anatomical examination of leg telangiectases with duplex scanning. J Dermatol Surg Oncol 19:940–945.Google Scholar
  12. 12.
    Thibault P, Bray A, Wlodarczyk J, Lewis W (1990) Cosmetic leg veins: Evaluation using duplex venous imaging. J Dermatol Surg Oncol 16:612–618.Google Scholar
  13. 13.
    Schalin L (1981) Arteriovenous communications in varicose veins localized by thermography and identified by operative microscopy. Acta Chir Scand. 147:409–420.Google Scholar
  14. 14.
    Sommer A, Van Mierlo PLH, Neumann HAM, Kessels AGH (1997) Red and blue telangiectasias. Dermatol Surg 23:55–59.Google Scholar
  15. 15.
    Wokalek H, Vanscheidt W, Martay K, Leder O (1989) Morphology and localization of sunburst varicosities: An electron microscopic and morphometric study. J Dermatol Surg Oncol 15:149–154.Google Scholar
  16. 16.
    Goldman MP, Sadick NS, Weiss RA (1995) Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Dermatol Surg 21:19–29.Google Scholar
  17. 17.
    Partsch H, Baccalini U, Stemmer R (1997) Questionaire regarding the practice of sclerotherapy. Phlebology 12:43–55.Google Scholar
  18. 18.
    Sadick NS (1990) Treatment of varicose and telangiectatic leg veins with hypertonic saline: A comparative study of heparin and saline. J Dermatol Surg Oncol 16:24–28.Google Scholar
  19. 19.
    Gallagher PG (1992) Varicose veins—primary treatment with sclerotherapy. J Dermatol Surg Oncol 18:39–42.Google Scholar
  20. 20.
    Sadick NS (1991) Sclerotherapy of varicose and telangiectatic leg veins. J Dermatol Surg Oncol 17:65–70.Google Scholar
  21. 21.
    Zimmet SE (1993) The prevention of cutaneous necrosis following extravasation of hypertonic saline and sodium tetradecyl sulfate. J Dermatol Surg Oncol 19:641–646.Google Scholar
  22. 22.
    Bodian EL (1989) Sclerotherapy: A personal appraisal. J Dermatol Surg Oncol 15:156–161.Google Scholar
  23. 23.
    Tretbar LL (1989) Injection sclerotherapy for spider telangiectasias: A 20-year experience with sodium tetradecyl sulfate. J Dermatol Surg Oncol 15:223–225.Google Scholar
  24. 24.
    Puissegur Lupo ML (1989) Sclerotherapy: Review of results and complications in 200 patients. J Dermatol Surg Oncol 15:214–219.Google Scholar
  25. 25.
    Conrad P, Malouf GM, Stacey MC (1995) The Australian Plidocanol (Aethoxysklerol) study. Dermatol Surg 21:334–336.Google Scholar
  26. 26.
    Weiss RA, Weiss MA (1990) Resolution of pain associated with varicose and telangiectatic leg veins after compression sclerotherapy. J Dermatol Surg Oncol 16:333–336.Google Scholar
  27. 27.
    Goldman MP, Fronek A (1989) Anatomy and pathophysiology of varicose veins. J Dermatol Surg Oncol 15:138–145.Google Scholar

Copyright information

© International College of Angiology, Inc 1999

Authors and Affiliations

  • Imre Bihari
    • 2
  • Éva Magyar
    • 1
  1. 1.PathologyHIETE Postgraduate Medical UniversityBudapestHungary
  2. 2.Cardio-Vascular SurgeryHIETE Postgraduate Medical UniversityBudapestHungary

Personalised recommendations